NBDF’s Pathway to Cures Launches Spark Biomedical’s LUNA Trial to Explore Non-Drug Treatment for Heavy Menstrual Bleeding For many women and adolescent girls living with inherited bleeding disorders, heavy menstrual…
Roseman University Establishes 120,000-Square-Foot Bioventures Hub in Las Vegas to Accelerate Life Science Innovation Roseman University of Health Sciences has officially launched Roseman Bioventures in Las Vegas, marking a significant…
U.S. Food and Drug Administration Approves Updated Label to Enable Faster Thawing of ADSTILADRIN® (nadofaragene firadenovec-vncg) Ferring Pharmaceuticals has announced that the U.S. Food and Drug Administration has approved an…
Medpace Holdings, Inc. Schedules Release of First Quarter 2026 Financial Results for April 22, 2026 Medpace Holdings has announced the upcoming release of its financial results for the first quarter…
Enhancing Digital Health Capabilities Through Integrated Blended Learning Approaches Across many low- and middle-income countries, the promise of digital health transformation is often constrained by a persistent and complex reality:…
Grifols Advances Plans to Launch IPO for Its U.S. Biopharma Division Grifols has taken a significant strategic step toward reshaping its corporate structure and accelerating long-term growth, as its Strategy…
WuXi Biologics Announces Record-Breaking Financial Performance for Fiscal Year 2025 WuXi Biologics has reported a year of strong financial performance and operational expansion for the fiscal year ending December 31,…
Celltrion Unveils KRW 1.2 Trillion Investment to Expand Drug Substance Manufacturing in Songdo, Boosting Total Capacity to 570,000 Liters Celltrion has unveiled an ambitious large-scale investment strategy exceeding KRW 1…
Alnylam Drives Innovation in ATTR-CM Care Through Strategic Collaboration with Viz.ai and Ongoing Support for the American Heart Association Alnylam Pharmaceuticals is spearheading a comprehensive, system-wide initiative aimed at transforming…
BioNTech presents new ELCC 2026 data underscoring the strength and differentiation of its late-stage lung cancer pipeline BioNTech has announced that it will showcase new clinical data from its expanding…
Dupixent Approved in Japan as the First Targeted Therapy for Adults with Bullous Pemphigoid Regeneron Pharmaceuticals and Sanofi have announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has…
AbbVie Becomes Official Pharmaceutical Partner of Major League Baseball AbbVie has unveiled a landmark multi-year partnership with Major League Baseball (MLB), officially naming the company as the league’s “Official Pharmaceutical…